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The goal of the present study was to evaluate the effects of
Ang II on the current produced by the Na1-Ca21 ex-
changer (INCX) working in the reverse mode and the
possible autocrine role played by the release of endothelin
(ET) in these actions. INCX was studied in isolation in cat
cardiac myocytes. Angiotensin II (Ang II) (100 nmol/L)
increased INCX at potentials higher than 0 mV (at 160
mV: 2.0760.22 pA/pF in control versus 2.7360.22 pA/pF
in Ang II, n59; P<0.05). The increase in INCX induced by
Ang II was prevented by the treatment of the cells with
the unspecific blocker of the ET receptors, TAK 044 (1
mmol/L) (at160 mV: 2.1560.27 pA/pF in control versus
2.0160.26 pA/pF in Ang II, n55, NS). These results show,
for the first time, that the effect of Ang II on INCX is the
result of the autocrine actions of ET released by the
octapeptide.
Previous experimental evidence indicates that some car-diovascular effects initially thought to be mediated by
angiotensin II (Ang II) were, in fact, due to the release of
endogenous endothelin (ET). In cultured neonatal rat cardio-
myocytes, Ito et al1 reported inhibition of Ang II–induced
hypertrophy with a blocker of ETA receptors (BQ123) or
antisense oligonucleotides directed against mRNA of pre-
proET. In rats, the elevation of blood pressure induced by
infusion of Ang II was reversed by the ETA blocker PD
155080.2 The goal of the present study was to evaluate, in
isolated myocytes, the effects of Ang II on the current
produced by the NCX (INCX) working in the reverse mode and
the possible autocrine role played by the release of ET in
these actions. We present novel evidence that demonstrates,
for the first time, that the reverse mode of the cardiac NCX is
stimulated by endogenous ET released by the myocytes on
Ang II regulation.
Materials and Methods
Cat cardiac myocytes were isolated according to the technique
previously described.3 Animals were provided by a local supplier
(San Cayetano, Monte Grande, Argentina) and procedures were per-
formed according to the Guide for the Care and Use of Laboratory
Animals (US Department of Health and Human Services). The deter-
mination of the NCX current (INCX) was performed under the conditions
previously described by Hobai and O’Rourke4 with some modifications.
In some experiments, L-type Ca21 current (ICa) was recorded. The
composition of solutions and other details are described in an expanded
Materials and Methods section that can be found in the online data
supplement, available at http://www.circresaha.org.
Results and Discussion
Whereas the contribution of the reverse mode of the NCX to
basal cardiac contraction is controversial,5 increases in con-
tractility due to stimulation of this mode of the NCX have
been reported to be present after the effects of agonists such
as Ang II6 or ET.7 Therefore, since the initial goal of the
present study was the evaluation of the effects of Ang II on
the reverse mode of the NCX, we measured INCX under
recording conditions that favor this mode over the forward
mode. Figure 1 shows the inhibitory effects of the NCX
blocker KB-R7943 (KBR, 10 mmol/L) on whole-cell currents
recorded under conditions of INCX isolation. Note that KBR
blocked both forward and reverse modes of NCX, as it was
previously reported for this concentration of the agent.8
Lower concentrations of KBR were proven to block selec-
tively the reverse mode of NCX.8 Consistently, no effects of
this drug on the forward mode were observed when 5 mmol/L
KBR was used (shown in the online data supplement). Ni21
(10 mmol/L), another NCX antagonist, blocked the current
registered at 160 mV by 8565% (n511). On average, the
apparent reversal potentials (Erev) of INCX were 244.462.5
mV (n56) and 239.564.1 mV (n511) estimated as the zero
current potential of the KBR- and Ni21-sensitive currents,
respectively. These values are similar to the INCX Erev values
reported by other authors working in similar conditions to
those of the present study.4 The above experiments allowed
us to conclude that the whole-cell currents registered were
mainly underlain by the NCX (INCX).
Ballard and Schaffer9 reported that Ang II or ET increased
the activity of the NCX in canine cardiac sarcolemmal
vesicles. Thus, we next examined whether Ang II was able to
affect INCX in isolated cat cardiac myocytes. Figure 2A depicts
the time course of the effect of Ang II (100 nmol/L) on the
current recorded at 160 mV in a single myocyte. Ang II
induced a gradual increase in the current that reaches steady-
state values after 5 minutes of administration of the peptide.
Average data of the current recorded at 160 mV in the
absence and presence of Ang II are shown in Figure 2C. This
current increased by 24.764.9% (n526) in the presence of
Ang II. The Ang II type 1 receptor (AT1) antagonist losartan
(1 mmol/L) reversed the effects of Ang II (data not shown).
The outward current recorded at160 mV is mostly but not
totally INCX because a small remnant current is present after
the effects of the NCX blockers Ni21 or KBR. Thus, the
possibility that the Ni21-insensitive current could be affected
by Ang II was evaluated. No increase in outward current was
induced by Ang II (100 nmol/L) in the presence of Ni21
(10 mmol/L) (0.7560.31 pA/pF in Ni21 and 0.7860.36
pA/pF in Ni21 plus Ang II, n55; NS), indicating that the
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current affected by Ang II is most likely INCX. Moreover, to
confirm that Ang II affects INCX, we studied the effects of this
peptide on the KBR-sensitive currents. Figure 2D shows
average current density-voltage relations obtained in 9 myo-
cytes exposed to 10 mmol/L KBR after having obtained the
increase in the whole-cell current by Ang II. Ang II induced
a significant increase in outward currents at potentials posi-
tive to 0 mV. KBR blocked the currents recorded after Ang II
to the same extent of those recorded in the absence of the
peptide (Figure 1). Figure 1E shows the effects of Ang II on
the average current-voltage relation for the KBR-sensitive
currents, corresponding to INCX, obtained by subtracting the
currents in KBR to those recorded in both control and in Ang
II. Ang II significantly increased INCX at potentials positive to
0 mV. At 160 mV, INCX increased by 38.7614.6% in the
presence of Ang II (n59).
We next examined whether the Ang II–induced increase in
INCX observed in the present study was produced by release of
endogenous ET. For this purpose, we pretreated the cells with
the nonselective blocker of ET receptors, TAK 044 (1
mmol/L). This blocker did not affect basal current (at 160
mV: 2.5960.15 pA/pF in control versus 2.4560.12 pA/pF in
TAK 044-treated myocytes, n513; NS). Figure 3A shows the
time course of effects of Ang II in the presence of TAK 044
on the current registered at 160 mV. In the presence of the
ET receptor blocker, Ang II failed to induce enhancement of
this current. On average, no effects of Ang II were
observed in the presence of TAK 044 on the current
recorded at 160 mV (Figure 3C) or at any of the tested
voltages (Figure 3D). In addition, no effects of Ang II in
the presence of TAK 044 were observed on the Ni21-
sensitive currents, representing INCX (at 160 mV:
Figure 1. Characterization of INCX. A, Fami-
lies of representative whole-cell currents
evoked by depolarizing pulses between 280
to 1100 mV from a holding potential of 240
mV, recorded in a myocyte in the absence
and presence of KBR (10 mmol/L). Pulses
(260 ms in duration) were delivered at 0.1
Hz. B, Voltage dependence of the average
current density measured in 6 myocytes
exposed to KBR (10 mmol/L). C, Average
current-voltage relations of the KBR-
sensitive currents, representing INCX (n56).
Figure 2. Ang II effects on INCX. A, Time
course of effects of Ang II on the current
registered at 160 mV from a holding
potential of 240 mV, recorded in a single
myocyte. Pulses were delivered at 0.1
Hz. B, Representative traces of whole-
cell currents corresponding to the points
indicated in panel A. C, Average data of
current density recorded at 160 mV
before and after the addition of Ang II
(100 nmol/L) (n526). D, Ang II (100
nmol/L) and KBR (10 mmol/L) effects on
average current-voltage relations evoked
by the voltage protocol of Figure 1
(n59). E, Ang II effects on average
current-voltage relations for the KBR-
sensitive current, corresponding to INCX
(n59). *Ang II statistically different from
control.
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2.1560.27 pA/pF in TAK 044 versus 2.0160.27 pA/pF in
Ang II plus TAK 044, n55; NS).
To rule out the possibility that the ET receptor blocker
TAK 044 is acting on the Ang II receptors, we performed
experiments in which the L-type calcium current (ICa) was
measured in the absence and presence of Ang II (100 nmol/L)
with or without TAK 044 (1 mmol/L) in the extracellular
solution. We have recently reported that Ang II enhances ICa
via activation of AT1 receptors in cat cardiac myocytes.3
Under the recording conditions of the present study, the peak
ICa recorded at 0 mV increased by 2368% (n55) after 10
minutes in the presence of Ang II. A similar increment in ICa
after 10 minutes of Ang II was observed in the presence of
TAK 044 (2167%, n55). These results suggest that this ET
receptor blocker did not unspecifically bind to AT1 receptors
and that the endogenous ET released by Ang II did not affect
ICa. The previously reported failure of ET-1 to affect ICa when
standard whole-cell configuration is used can account for the
last result.10
Taken together, the above results allow us to suggest that in
cardiac myocytes the stimulation of INCX induced by Ang II is,
in fact, mediated by endogenous ET released by Ang II. The
major finding of this study is the demonstration at the cardiac
single-cell level of the existence of an autocrine mechanism
in the heart involving the myocyte as the source and target of
ET. Additional observations and extended discussion of the
results are presented in the online data supplement.
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Figure 3. Inhibition of Ang II effects on
INCX by the ET receptor antagonist TAK
044. A, Time course of effects of Ang II
in the presence of TAK 044 on the cur-
rent registered at 160 mV from a holding
potential of 240 mV, recorded in a single
myocyte. Pulses were delivered at 0.1
Hz. B, Representative traces of whole-
cell currents corresponding to the points
indicated in panel A. C, Average data of
current density recorded at 160 mV
before and after the addition of Ang II
(100 nmol/L) to the solution containing
TAK 044 (1 mmol/L) (n513). D, Ang II
effects in the presence of TAK 044 on
average current-voltage relations evoked
by the same voltage protocol of Figure 1
(n57).
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